STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (20,144,478)	$ (7,471,090)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	173,185	302,871
Issuance of common stock, warrants and options for services	534,425	364,318
Modification of warrants issued for services	76,991	0
Equity based compensation	1,493,134	2,087,718
Common stock contributed to 401 (k) plan	115,970	119,190
Impairment loss on abandonment of patents	240	10,651
Loss on retired equipment	0	4,199
Loss (gain) on derivative instruments	1,053,755	(7,363,854)
(Increase)/decrease in assets:
Receivables	(6,177)	(5,125)
Deferred rent	571,125	409,400
Prepaid expenses	(73,752)	529,511
Inventory used for R&D and manufacturing	(397,076)	248,892
Deposits	(200,000)	(400,000)
Increase/(decrease) in liabilities:
Accounts payable	(571,756)	560,521
Accrued expenses	256,199	392,311
Deferred revenue	46	45
Due to employees	(76,235)	67,752
Deferred rent liability	(2,245)	640
Net cash used in operating activities	(17,196,649)	(10,142,050)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of equipment	(66,912)	(93,419)
Expenditures for patent costs	(33,262)	(24,446)
Net cash used in investing activities	(100,174)	(117,865)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants	28,428,641	9,807,375
Proceeds from exercise of warrants	3,118,387	0
Payments on oblgations under capital leases	(6,104)	(4,432)
Net cash provided by financing activities	31,540,924	9,802,943
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	14,244,101	(456,972)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	41,612	3,941,042
CASH AND CASH EQUIVALENTS, END OF PERIOD	14,285,713	3,484,070
ISSUANCE OF WARRANTS:
Increase in derivative liabilities	(7,791,448)	(4,200,000)
Decrease in additional paid-in capital	7,791,448	4,200,000
Total	0	0
ISSUANCE OF ADDITIONAL SHARES
Increase in common stock	(15,631)	0
Increase in additional paid-in capital	(1,101,786)	0
Decrease in additional paid-in capital	1,117,417	0
Total	0	0
EXERCISE OF WARRANTS
Increase in common stock	(657)	0
Increase in additional paid-in capital	(1,161,274)	0
Decrease in derivative liabilities	1,161,931	0
Total	0	0
RECLASSIFICATION OF WARRANTS FROM LIABILITY TO EQUITY
Increase in additional paid-in capital	(1,308,528)	0
Decrease in derivative liabilities	1,308,528	0
Total	0	0
ISSUANCE OF COMMON STOCK FOR PREPAID SERVICES:
Increase in additional paid-in capital	(6,612)	(117,090)
Increase in prepaid expenses	6,612	117,090
Total	0	0
ISSUANCE OF COMMON STOCK FOR PATENT COSTS
Increase in common stock	(87)	0
Increase in additional paid-in capital	(9,912)	0
Increase in patent costs	9,999	0
Total	0	0
PATENT COSTS INCLUDED IN ACCOUNTS PAYABLE
Increase in patent costs	6,099	13,145
Increase in accounts payable	(6,099)	(13,145)
Total	0	0
NON-CASH EQUIPMENT COSTS
Increase in research and office equipment	20,605	45,236
Increase in accounts payable	(24,024)	(8,614)
Decrease/(increase) in capital lease obligations	3,419	(36,622)
Total	0	0
MODIFICATION OF WARRANTS:
Increase additional paid-in capital	0	(59,531)
Decrease in additional paid-in capital	0	59,531
Total	0	0
CAPITAL LEASE PAYMENTS INCLUDED IN ACCOUNTS PAYABLE:
Decrease in capital lease obligation	47	1,197
Increase in accounts payable	(47)	(1,197)
Total	0	0
Cash expenditures for interest expense	$ 139,313	$ 126,950